Johan Palm
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 8
-
- Pharmacological Effects and Toxicity Studies 5
- Pharmaceutical studies and practices 2
- Co-authors
- Per Artursson (3 shared papers)Christel A. S. Bergström (3 shared papers)Kim L. R. Brouwer (1 shared paper)Raymond Evers (1 shared paper)Yaofeng Cheng (1 shared paper)Dietrich Keppler (1 shared paper)Daniel A.J. Bow (1 shared paper)Bruno Stieger (1 shared paper)
- Journals
- Molecular Pharmaceutics (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Drug Metabolism and Disposition (2 papers)Pharmaceutical Research (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Johan Palm
11 papers receiving 408 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 150
- Oncology 337
- Pediatrics, Perinatology and Child Health 193
- Biochemistry 23
- Infectious Diseases 55
Countries citing papers authored by Johan Palm
This map shows the geographic impact of Johan Palm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Palm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Palm more than expected).
Fields of papers citing papers by Johan Palm
This network shows the impact of papers produced by Johan Palm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Palm. The network helps show where Johan Palm may publish in the future.
Co-authors
The 25 scholars most cited alongside Johan Palm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 191 | |
| 2 | 2011 | 99 | |
| 3 | 2013 | 31 | |
| 4 | 2011 | 30 | |
| 5 | 2017 | 29 | |
| 6 | 2013 | 13 | |
| 7 | 2017 | 10 | |
| 8 | 2010 | 7 | |
| 9 | 2022 | 4 | |
| 10 | 2017 | 3 | |
| 11 | 2025 | 1 |
About Johan Palm
Johan Palm is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Infectious Diseases, Pharmaceutical Science and Surgery, having authored 11 papers that have together received 418 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (5 papers), Drug Solubulity and Delivery Systems (3 papers), HIV/AIDS drug development and treatment (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pharmaceutical studies and practices (2 papers), Cholesterol and Lipid Metabolism (1 paper) and Protein purification and stability (1 paper). The work is most often cited by research in Pharmacology (150 citations), Oncology (337 citations), Pediatrics, Perinatology and Child Health (193 citations), Biochemistry (23 citations) and Infectious Diseases (55 citations). Johan Palm has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Per Artursson, Christel A. S. Bergström, Kim L. R. Brouwer, Raymond Evers, Yaofeng Cheng, Dietrich Keppler, Daniel A.J. Bow, Bruno Stieger, Keith Hoffmaster and Yurong Lai. Their work appears in journals such as Molecular Pharmaceutics, European Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition, Pharmaceutical Research and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.